5/15/24 17:49 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Diaz Paul J | UT | DO | P,CEO | 1 | S.m | -5,729 | 25.14 | 0 | -228 | | 1,066 | D | | | | | | | | | | | | | | |
5/15/24 17:48 | 5/13/24 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Newcomer Lee Nisley | UT | D | | 1 | S | -157 | 25.30 | 0 | -6 | | 67 | D | | | | | | | | | | | | | | |
5/15/24 17:09 | 5/13/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sabens Andrea | MA | O | Chief Ac | 14 | S.m | -1,083 | 73.54 | 0 | -15 | | 63 | D | | | | | | | | | | | | | | |
3/19/24 16:30 | 3/15/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Marshall Robert J. Jr. | MA | O | CFO,Trea | 6 | S.m | -5,863 | 72.89 | 0 | -80 | | 133 | D | | | | | | | | | | | | | | |
3/11/24 16:30 | 3/7/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Blanchfield Paul | MA | O | P | 6 | S.m | -2,070 | 66.91 | 0 | -31 | | 103 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | 3 | S.d | -22,294 | 522.72 | 0 | -43 | | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | 2 | S.d | -1,816 | 505.76 | 0 | -4 | | 9 | D | | | | | | | | | | | | | | |
3/7/24 16:30 | 3/5/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leno Sam R | MA | D | | 3 | S.dm | -2,293 | 68.46 | 0 | -33 | | 58 | D | | | | | | | | | | | | | | |
3/5/24 20:28 | 3/4/24 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Heino Mary Anne | MA | D | | 7 | S.dm | -22,451 | 72.45 | 0 | -310 | | 729 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 3/2/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Basta James | MA | O | EVP,GC | 4 | S.d | -278 | 33.38 | 0 | -8 | | 82 | D | | | | | | | | | | | | | | |
3/5/24 16:10 | 7/3/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Clark Eliana | MA | O | EVP,Chie | 5 | S.dm | -472 | 37.45 | 0 | -13 | | 71 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | 1 | S.d | -4,705 | 573.87 | 0 | -8 | | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | 1 | S.d | -13,296 | 570.01 | 0 | -23 | | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | 3 | S.d | -17,402 | 534.58 | 0 | -33 | | 79 | D | | | | | | | | | | | | | | |
2/2/24 19:55 | 2/2/24 | IONS | Ionis Pharmaceuticals Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hougen Elizabeth L | CA | O | EVP,Fina | 4 | S.d | -956 | 45.17 | 0 | -21 | | 93 | D | | | | | | | | | | | | | | |
1/10/24 16:15 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Sepp-Lorenzino Laura | MA | O | EVP,Chie | 3 | S.m | -412 | 32.55 | 0 | -13 | | 46 | D | | | | | | | | | | | | | | |
1/5/24 16:51 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Leonard John M | MA | DO | P,CEO | 2 | S | -815 | 31.46 | 0 | -26 | | 905 | D | | | | | | | | | | | | | | |
1/5/24 16:50 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lebwohl David | MA | O | EVP,Chie | 2 | S | -268 | 31.83 | 0 | -8 | | 54 | D | | | | | | | | | | | | | | |
1/5/24 16:49 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Goddard Glenn | MA | O | EVP,CFO | 2 | S | -248 | 31.87 | 0 | -8 | | 41 | D | | | | | | | | | | | | | | |
1/5/24 16:46 | 1/4/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hicks Derek | MA | O | EVP,Chie | 2 | S | -182 | 31.93 | 0 | -6 | | 37 | D | | | | | | | | | | | | | | |
1/3/24 10:41 | 1/2/24 | VNRX | Volitionrx Ltd | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Eight Corp Ltd | Y8 | T | | 2 | S | -33 | 0.8250 | 0 | -40 | 0 | 12,025 | I | | | | | | | | | | | | | | |
12/8/23 17:28 | 12/6/23 | AWH | Aspira Women'S Health Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Merchant Minh Hoang | TX | O | Secretar | 1 | S | -3 | 3.37 | 0 | -1 | | 27 | I | | | | | | | | | | | | | | |
12/5/23 16:19 | 12/1/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Riggsbee Richard Bryan | UT | O | CFO | 5 | S | -1,582 | 18.61 | 0 | -85 | | 374 | D | | | | | | | | | | | | | | |
11/2/23 16:42 | 10/31/23 | NTLA | Intellia Therapeutics, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Bhanji Muna | MA | D | | 3 | S | -91 | 37.93 | 0 | -2 | | 13 | D | | | | | | | | | | | | | | |
10/17/23 10:06 | 10/13/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Lilly Jason Warren | MI | O | VP | 2 | S | -35 | 15.60 | 0 | -2 | | 27 | D | | | | | | | | | | | | | | |
10/13/23 17:03 | 6/2/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Baylor-Henry Minnie | MA | D | | 1 | S | -1 | 86.17 | 0 | 0 | | 0 | I | | | | | | | | | | | | | | |
10/12/23 11:54 | 10/11/23 | NEOG | Neogen Corp | MI | Health | Diagn | In Vitro & In Vivo Diagnostic | Boehm William T | | D | | 2 | S.d | -74 | 18.17 | 0 | -4 | | 25 | D | | | | | | | | | | | | | | |
9/19/23 16:30 | 9/15/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Niedzwiecki Daniel | MA | O | See Rema | 4 | S.dm | -1,820 | 77.81 | 0 | -23 | | 75 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | 2 | S.dm | -9,806 | 478.52 | 0 | -20 | | 597 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | 2 | S.d | -8,658 | 508.47 | 0 | -17 | | 5 | D | | | | | | | | | | | | | | |
6/14/23 16:55 | 6/13/23 | TKNO | Alpha Teknova, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Hood Lisa | CA | O | Chief Pe | 2 | S | -50 | 3.42 | 0 | -15 | | 45 | D | | | | | | | | | | | | | | |
6/2/23 18:15 | 6/2/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Spiegelman Daniel K | UT | D | | 1 | S | -199 | 23.01 | 0 | -9 | | 40 | D | | | | | | | | | | | | | | |
4/19/23 17:32 | 4/17/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Montagut Etienne | MA | O | Chief Bu | 4 | S.m | -2,952 | 77.62 | 0 | -38 | | 87 | D | | | | | | | | | | | | | | |
3/29/23 17:51 | 3/27/23 | LNTH | Lantheus Holdings, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Markison Brian A | MA | D | | 1 | S | -1,078 | 81.13 | 0 | -13 | | 19 | D | | | | | | | | | | | | | | |
3/28/23 17:23 | 3/27/23 | MYGN | Myriad Genetics Inc | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Lambert Nicole | UT | O | COO | 2 | S | -451 | 22.98 | 0 | -20 | | 241 | D | | | | | | | | | | | | | | |
3/13/23 18:30 | 3/3/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Engelson Erik T. | CA | DO | P,Chief | 1 | S.d | -657 | 1.04 | 0 | -635 | | 261 | D | | | | | | | | | | | | | | |
3/13/23 17:10 | 3/3/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Narido Richard Clavano | CA | O | CFO | 1 | S.m | -29 | 1.00 | 0 | -29 | | 78 | D | | | | | | | | | | | | | | |
3/13/23 17:09 | 3/3/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Kevin Walter | CA | O | Chief Re | 1 | S.m | -74 | 0.6604 | 0 | -112 | | 235 | D | | | | | | | | | | | | | | |
3/13/23 17:08 | 3/3/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Allen Anthony Joseph | CA | O | Chief Op | 1 | S | -8 | 1.00 | 0 | -8 | | 137 | D | | | | | | | | | | | | | | |
2/22/23 16:15 | 2/17/23 | QDEL | Quidelortho Corp | | Health | Diagn | In Vitro & In Vivo Diagnostic | Buechler Kenneth F | CA | D | | 1 | S.d | -729 | 90.26 | 0 | -8 | | 70 | D | | | | | | | | | | | | | | |
2/21/23 12:38 | 2/16/23 | LHDX | Lucira Health, Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Kashmolah Ghazi | CA | O | Ex VP,Ch | 1 | S | -1 | 0.2701 | 0 | -5 | | 134 | D | | | | | | | | | | | | | | |
2/17/23 17:06 | 2/16/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | 1 | S.d | -1,119 | 511.68 | 0 | -2 | | 3 | D | | | | | | | | | | | | | | |
2/17/23 17:04 | 2/15/23 | IDXX | Idexx Laboratories Inc /de | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Turner Kathy V | ME | O | SVP | 3 | S.dm | -2,029 | 506.09 | 0 | -4 | | 7 | D | | | | | | | | | | | | | | |